SAN FRANCISCO, Sept. 13, 2016
SAN FRANCISCO, Sept. 13, 2016 /PRNewswire/ -- Cor, a transformative general wellness product that delivers personalized health insights from a single drop of blood, is among a select group of Silicon Valley startups scheduled to present at the 2016 GSV Pioneer Summit on September 14. Bob Messerschmidt, Founder and CEO of Cor, will represent the company during a panel titled "The Stars of Tomorrow" where he and 14 other executives from Silicon Valley's most compelling seed stage startups will share their most successful pitches.
The presenting companies consist of young startups that have raised $500 thousand to $4 million and are poised to disrupt billion-dollar industries. The selected startups are top innovators in a wide range of industries from AI to space, among others. In addition to Cor, presenting companies include: Bagaveev Corporation, Breinify, Diverst, Elsa, FLEX, Kyndi, Moti, Resoltz, Sense.ly, Singularity Networks, Vinsight, and Zeal Learning.
During the panel, Messerschmidt will exclusively reveal the secrets to a successful investor pitch and share personal examples from his company, Cor. The company saw great success during its official launch on Indiegogo, raising more than 231 percent of the company's initial goal. Backers were drawn to Cor's bold mission of bringing at-home health monitoring to the next level. The company uses patented state-of-the-art spectroscopic technology and a tiny sample of blood to report overall trends and offer lifestyle recommendations based on indicators such as cholesterol, fasting blood glucose, inflammation and triglycerides.
"The GSV Pioneer Summit brings together cream-of-the-crop entrepreneurs and encourages transformative companies with groundbreaking ideas to deeply impact global innovation," said Messerschmidt. "I'm looking forward to joining some of the best business leaders and sharing my passion--bringing valuable health insights to the home in a way that's convenient. While Cor's technology and concept is considered innovative now, I believe accurate, accessible health monitoring will soon be the industry standard."
The two-day GSV Pioneer Summit is to be held on September 14-15 at the GSVlabs office in Redwood City, CA. Over the two-day period, the conference will bring together more than 1,200 of the world's most driven leaders, founders and investors in the technology industry to strengthen and expand a community of forward thinkers invested in making the world more susceptible to positive change and innovation.In addition to "The Stars of Tomorrow," agenda topics will include: Exponential Machines, Human Renaissance, Sustainable World, Commerce Reimagined, and Moonshot Ideas. Sessions consist of keynotes, panel discussions, interactive workshops, hackathons and networking events led by over 100 founders and CEOs of leading venture-backed startups, top firm investors and global technology executives.
Cor is a powerful general wellness product that delivers personalized health insights from a single drop of blood. The Cor Reader uses patented vibrational spectroscopic technology to analyze a surface-level blood sample and report overall trends. The Cor App then delivers key insights and lifestyle improvement recommendations related to indicators such as cholesterol, fasting blood glucose, inflammation and triglycerides. Cor was founded in 2014 by Bob Messerschmidt and is backed by world-class medical advisors from Stanford, UCSF and Duke University. To learn more, visit http://knowyourcor.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bob-messerschmidt-founder-and-ceo-of-cor-to-present-at-gsv-pioneer-summit-alongside-silicon-valleys-most-compelling-early-stage-startups-300327074.html
SOURCE CorPR Newswire
Last updated on: 13/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.